MetaCap

Kalaris Therapeutics (KLRS) News

NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.28-0.07 (-5.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KLRS news summary

We found 2 recent headlines mentioning Kalaris Therapeutics (KLRS): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. KLRS is making an outsized move today, down 5.19% at $1.28, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Kalaris Therapeutics Reports Q3 Net Loss", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Kalaris Therapeutics headlines

Compare KLRS